Automated Suturing Devices Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented by Product (Disposable, Reusable), By Application (Cardiac, Orthopedic, Gastrointestinal, Ophthalmic, Dental, Gynecological, Other), By End User (Hospitals, Ambulatory Surgical Centers, Other), By Region, & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 4.58 Billion
CAGR (2026-2031)	7.66%
Fastest Growing Segment	Reusable
Largest Market	North America
Market Size (2031)	USD 7.13 Billion

Market Overview

The Global Automated Suturing Devices Market will grow from USD 4.58 Billion in 2025 to USD 7.13 Billion by 2031 at a 7.66% CAGR. Automated suturing devices are specialized medical instruments designed to facilitate precise tissue approximation and ligation while minimizing the manual dexterity and time required during surgical procedures. The primary drivers supporting the growth of this market include the increasing global preference for minimally invasive surgeries and the rising prevalence of chronic diseases that necessitate frequent operative interventions. This demand for surgical efficiency is intensified by workforce constraints in the healthcare sector. According to the American College of Surgeons, in 2024, the United States required the services of approximately 160,000 surgeons to meet public healthcare demands, highlighting the critical need for technologies that streamline operative workflows.

One significant challenge impeding market expansion is the substantial cost associated with acquiring these devices and the financial burden of the necessary specialized training for medical staff. This economic barrier limits the widespread adoption of automated suturing technologies particularly within smaller healthcare facilities and developing regions where budgetary constraints often prioritize essential medical supplies over automated surgical solutions.

Key Market Drivers

The rising prevalence of chronic diseases, particularly malignancies requiring resection, is a primary catalyst necessitating frequent surgical interventions and driving the demand for automated suturing devices. As patient populations expand and diagnostic capabilities improve, the volume of complex procedures requiring precise tissue approximation has surged, compelling healthcare providers to adopt efficient wound closure solutions. According to the American Cancer Society, January 2024, in 'Cancer Statistics, 2024', it was projected that over 2,001,000 new cancer cases would be diagnosed in the United States alone in 2024, creating a substantial baseline demand for oncological surgeries. This escalating disease burden necessitates advanced instrumentation that can streamline operations and ensure consistent closure quality across high-volume surgical schedules.

Concurrently, the increasing global adoption of minimally invasive surgical procedures is fundamentally reshaping the market, as these techniques demand specialized automated tools to perform suturing in restricted anatomical spaces. The shift from open surgery to laparoscopic and robotic-assisted formats relies heavily on devices that reduce operative time and enhance surgeon dexterity during intricate tasks. According to Intuitive Surgical, January 2024, in the 'Annual Report 2023', worldwide da Vinci procedures grew approximately 22% in 2023 compared to the prior year, reflecting this rapid transition toward automated and robotic workflows. To support this expanding surgical ecosystem, major industry players are maintaining significant commercial operations; for instance, according to Medtronic, in 2024, the company reported revenue of $8.4 billion for its Medical Surgical Portfolio, underscoring the massive financial scale of the surgical technologies market.

Download Free Sample Report

Key Market Challenges

The substantial cost associated with acquiring automated suturing devices and the financial burden of necessary specialized training constitute a primary impediment to market expansion. This economic barrier severely restricts the widespread adoption of these advanced surgical technologies, particularly within smaller healthcare facilities and developing regions where capital is limited. Hospitals in these areas often operate under tight budget constraints, forcing them to prioritize essential medical supplies over expensive automated solutions. Consequently, many institutions continue to rely on traditional manual suturing techniques despite the potential for improved operative efficiency.

This financial strain is further evidenced by recent industry data highlighting the precarious economic position of healthcare providers which restricts capital expenditure. According to the American Hospital Association, in 2024, the number of days cash on hand for hospitals and health systems had fallen by 28.3% since the start of 2022, significantly limiting their ability to invest in new medical technologies. This reduction in available liquidity directly hampers the growth of the Global Automated Suturing Devices Market, as procurement departments are compelled to defer the purchase of high-cost surgical instrumentation to maintain operational stability.

Key Market Trends

The rapid expansion into Ambulatory Surgical Center (ASC) settings is fundamentally altering device requirements, as these facilities increasingly undertake high-acuity procedures demanding superior operative efficiency. ASCs operate on tight turnover schedules where the speed and reliability of automated suturing are critical for maintaining profitability while ensuring patient safety. This shift toward complex outpatient care is evidenced by the rising financial value of surgical cases; according to Ambulatory Surgery Center News, March 2025, in the article 'Smaller ASCs See Big Revenue Gains', the average revenue per case in surgery centers rose to $6,400 in 2024, reflecting the migration of intensive surgeries that necessitate advanced closure technologies. Consequently, manufacturers are optimizing automated devices for portability and rapid deployment to suit this fast-paced ecosystem.

Concurrently, the advancement in robotic-assisted and powered suturing compatibility is driving significant market value, as surgeons seek instrumentation that integrates seamlessly with sophisticated operating platforms. This trend moves beyond simple mechanical assistance to fully powered, ergonomic instruments that reduce fatigue and improve precision during lengthy resections. The commercial viability of this high-tech segment remains robust as major players post strong gains in their surgical portfolios. According to Stryker, January 2025, in the 'Fourth Quarter and Full Year 2024 Operating Results', the company reported full-year net sales of $22.6 billion, representing a 10.2% organic increase driven largely by sustained demand in its MedSurg businesses. This growth underscores the accelerating adoption of advanced powered instrumentation within the broader surgical workflow.

Segmental Insights

The Reusable segment has emerged as the fastest-growing category in the Global Automated Suturing Devices Market, primarily due to its substantial economic benefits for healthcare facilities. Hospitals are increasingly prioritizing these devices to optimize operational budgets, as they eliminate the recurring procurement costs associated with single-use alternatives. Additionally, modern reusable instruments are engineered to withstand rigorous sterilization cycles, ensuring robust infection control and consistent clinical performance. This trend is further accelerated by the global healthcare sector’s initiative to minimize medical waste, making reusable solutions a strategic choice for sustainable and cost-effective surgical care.

Regional Insights

North America maintains a dominant position in the global automated suturing devices market, driven by a high volume of surgical procedures and the strong presence of key industry players. The region benefits from advanced healthcare infrastructure that facilitates the widespread adoption of minimally invasive surgical techniques. Additionally, supportive reimbursement policies from the Centers for Medicare & Medicaid Services encourage the utilization of these devices in clinical settings. The U.S. Food and Drug Administration further supports market stability through established regulatory pathways, ensuring the availability of safe and effective medical technologies.

Recent Developments

• In June 2025, Suturion announced the commercial launch of its Suture-TOOL device in the United States following successful regulatory clearances. The device, often described as a surgical sewing machine, was introduced to standardize the closure of the abdominal wall after open surgery. It automates the suturing process to ensure consistent adherence to the small-bites technique, which is clinically proven to reduce the risk of incisional hernias and other wound complications. This launch marked the company's entry into the U.S. market, offering healthcare providers a solution to improve patient safety and reduce healthcare costs associated with postoperative complications.
• In June 2024, LSI Solutions, Inc. obtained a De Novo classification order from the U.S. FDA for its Mi-CHORD System, an artificial chordae tendineae surgical replacement system. This prescription device utilizes the company's proprietary automated suturing technology to replace damaged mitral valve chords in patients with atrioventricular valve insufficiency. The system allows cardiac surgeons to place non-absorbable suture-based implants with high precision while the heart is either arrested or fibrillating. The regulatory decision classified the device into Class II, acknowledging its safety and effectiveness for enabling minimally invasive cardiac repair through automated suture placement.
• In April 2024, Medical Microinstruments, Inc. (MMI) received De Novo classification grant from the U.S. Food and Drug Administration (FDA) for its Symani Surgical System. This regulatory milestone established the system as a first-of-its-kind robotic platform authorized for soft tissue manipulation during open microsurgical procedures in the United States. The device features the world’s smallest wristed surgical instruments, designed to replicate the movements of a human hand at a micro-scale. It specifically addresses the challenges of suturing small anatomical structures, such as blood and lymphatic vessels, allowing surgeons to perform precise anastomosis and reconstruction with greater stability and control.
• In January 2024, EndoQuest Robotics formed a strategic partnership with OMNIVISION to integrate advanced imaging technology into its Flexible Robotic System. This collaboration involved incorporating the OCHFA CameraCubeChip, a high-performance medical-grade image sensor, into the robotic platform designed for endoluminal surgeries. The integration aimed to enhance visualization capabilities for surgeons performing minimally invasive procedures within the gastrointestinal tract, where precision is critical for tasks such as suturing and tissue removal. The partnership focused on improving surgical outcomes by combining flexible robotics with superior imaging to enable scar-free operations through the body's natural orifices.

Key Market Players

• Intuitive Surgical
• Medtronic
• Johnson and Johnson
• Medtronic
• Teleflex
• Aesculap
• LSI Solutions
• Corza Medical
• Zimmer Biomet
• LoneStar

By Application	By End User	By Region
Cardiac Orthopedic Gastrointestinal Ophthalmic Dental Gynecological Other	Hospitals Ambulatory Surgical Centers Other	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Automated Suturing Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Automated Suturing Devices Market, By Application:

• Cardiac
• Orthopedic
• Gastrointestinal
• Ophthalmic
• Dental
• Gynecological
• Other

• Automated Suturing Devices Market, By End User:

• Hospitals
• Ambulatory Surgical Centers
• Other

• Automated Suturing Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE